In 1972, Svetlana Mojsov was a PhD student at Rockefeller University in New York City under the tutelage of biochemist Bruce Merrifield, who had developed a new, efficient way to produce peptides in a lab (for which he would win a Nobel Prize in 1984) called solid-phase peptide synthesis. For her doctoral thesis, Mojsov used this method to achieve something that had eluded researchers for decades: She successfully synthesized glucagon, a complex hormone the body produces to raise blood sugar levels when necessary, which was of particular interest to endocrinologists as a potential treatment for diabetes
As with any injectable therapy, personalized patient assessment and ongoing monitoring are essential for maximizing benefits and minimizing risk
We shed some light on the situation, and now you can navigate with ease
Semaglutide helps people lose weight and keep it off, but just like with other chronic conditions, stopping the medicine may lead to the return of symptoms
Harding, A
By utilizing HRs as the effect measure, we ensured greater comparability among studies and enhanced the robustness and stability of the pooled estimate for the association between GLP-1RAs and AUD